NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and set off a ...
NEW YORK, March 26 (Reuters) - Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with mercurial White House economic policies that have roiled markets and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback